04/18/2020 / By Ethan Huff
March 12 was by and large the scariest moment thus far in the life of Dr. Ryan Padgett, an emergency room doctor who probably would have died from the Wuhan coronavirus (COVID-19) were it not for an experimental regimen of integrative medicine that he was given.
This date was when Dr. Padgett, who had been treating Wuhan coronavirus (COVID-19) patients himself, suddenly came down with a serious case of it, resulting in him having to be hospitalized.
He’d seen the horrors of countless others who suffered and died from the novel virus, but now he was facing it himself and declining quickly. And because there’s no known cure, he was as sure as dead.
The physicians treating him tried a ventilator, but Dr. Padgett’s symptoms only went from bad to worse. His fever, cough, and difficulty breathing quickly became kidney failure and heart problems.
Doctors assumed that he only had about another day or so to live, that is until another team of so-called “elite” doctors tried an experimental treatment on him that’s said to have been successfully used in China to treat the sickest of Wuhan coronavirus (COVID-19) patients.
Dr. Padgett was given a drug known as Actemra, originally designed to treat rheumatoid arthritis, along with high-dose vitamin C and various other therapies. And within just a few days, Dr. Padgett was on the mend.
As it turns out, Dr. Padgett’s body wasn’t failing due to the Wuhan coronavirus (COVID-19), but rather a “cytokine storm” in which his own immune system was in hyperdrive, a potentially deadly scenario.
Dr. Padgett’s body was so stricken with inflammation that his immune system had basically gone haywire. And it just so happens that Actemra combats cytokine storms, making it a near-perfect remedy for his condition.
Listen below to The Health Ranger Report as Mike Adams, the Health Ranger, talks with Dr. Shiva Ayyadurai about nutritional science and molecular simulations:
Keep in mind that Dr. Padgett is a six-foot-three, 44-year-old, 250-pound former football star who played for Northwestern University in the 1996 Rose Bowl, not an elderly person with preexisting conditions. In other words, he was the last person you might expect to fall ill with the Wuhan coronavirus (COVID-19).
But he did, and the good news is that Actemra and high-dose vitamin C appear to have done the trick.
“This is a movie-like save,” Dr. Padgett stated after his recovery. “It doesn’t happen in the real world often. I was just a fortunate recipient of people who said, ‘We are not done. We are going to go into an experimental realm to try and save your life.'”
Almost unbelievably, doctors observed dramatic increases in Dr. Padgett’s blood-oxygen levels after just four days of treatment. And on March 23, they were able to take him off life support.
Four days after that, Dr. Padgett had his breathing tube removed, and he slowly began to come out of his sedated coma. As time went on, he regained his senses, was able to video chat with his family, and ultimately lived to tell the story of his amazing recovery.
“It’s an incredible thing to survive a brush with death and not be able to see and be with your most loved people,” Padgett said. “And when everyone on staff who comes to see you has to be in a spacesuit, you just feel like this pariah. The isolation was pretty devastating at times.”
As it turns out, there was another woman in the same hospital as Dr. Padgett, 33 years old, who also had a cytokine storm and recovered after receiving the same experimental treatment.
To keep up with the latest news about the Wuhan coronavirus (COVID-19), be sure to check out Pandemic.news.
Sources for this article include:
Tagged Under:
Actemra, China, Chinese Virus, coronavirus, covid-19, cytokine storm, disease, drug, emergency room doctor, global emergency, Global Pandemic, infection, infections, natural cures, natural medicine, novel coronavirus, outbreak, pandemic, rheumatoid arthritis, Ryan Padgett, virus, vitamin C, Wuhan, Wuhan coronavirus
This article may contain statements that reflect the opinion of the author
COPYRIGHT © 2017 OUTBREAK NEWS